*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.
Revvity (RVTY) is poised to capture investor attention as it approaches its earnings announcement on October 27, 2025, with a market cap of over $10.8 billion underscoring its significant presence in the industry. Analysts are closely watching the company's ability to meet or exceed the EPS estimate of $1.14, with the whisper number slightly higher at $1.16, suggesting a cautious optimism among investors. Revenue is projected at $699.36 million, a figure that will be scrutinized for signs of strategic growth or operational efficiency. In the absence of recent news, the focus remains on Revvity's ability to leverage its market position and deliver results that align with or surpass these expectations, potentially setting the stage for a positive market reaction.
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally. The company is headquartered in Waltham, Massachusetts.
Website: https://www.revvity.com
Average Sentiment Score:
Overall Sentiment: